Hester Biosciences Ltd.

View in App
1683.30 +10.00 ▲0.6%

28 September 2023, 04:01:00 PM
Volume: 223

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hester.in
Market Cap 1,432.47 Cr.
Enterprise Value(EV) 1,685.81 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 33.54 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 50.19 Trailing Twelve Months Ending 2023-06
Industry PE 37.52 Trailing Twelve Months Ending 2023-06
Book Value / Share 335.10 Trailing Twelve Months Ending 2023-06
Price to Book Value 5.02 Calculated using Price: 1,683.30
Dividend Yield 0.48 Period Ending 2023-03
No. of Shares Subscribed 0.85 Cr. 8,506,865 Shares
FaceValue 10
About Hester Biosciences Ltd.
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Hester Biosciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Hester Biosciences Ltd. Performance

View details >>
1 Day
+0.60%
1 Week
-0.26%
1 Month
-0.52%
3 Month
-1.43%
6 Month
+2.38%
1 Year
-17.62%
2 Year
-33.01%
5 Year
+50.29%
10 Year
+1458.61%

Hester Biosciences Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.73 20.56 20.38 17.57 25.59 16.38 16.16 16.17 10.39
Return on Capital Employed (%) 17.26 18.98 19.75 20.20 26.64 16.53 17.33 14.12 9.60
Return on Assets (%) 8.84 11.08 11.43 10.10 14.97 9.04 8.70 8.11 4.55

Hester Biosciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 75 85 102 122 141 177 201 228 260 280
Non Curr. Liab. 20 38 41 48 44 70 97 114 198 233
Curr. Liab. 45 35 38 38 55 49 83 61 97 149
Minority Int. 1 3 5 5 4 4 5 8 7 9
Equity & Liab. 142 160 186 213 244 299 387 411 562 670
Non Curr. Assets 85 100 112 133 146 158 227 250 367 442
Curr. Assets 57 60 74 80 98 142 159 162 195 228
Misc. Exp. not W/O
Total Assets 142 160 186 213 244 299 387 411 562 670

Hester Biosciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 90 101 123 136 178 183 214 235 266 303
Other Income 0 1 0 3 7 6 5 14 15 13
Total Income 90 102 124 138 185 190 219 249 281 316
Total Expenditure -65 -68 -82 -89 -110 -128 -146 -175 -216 -246
PBIDT 26 34 41 50 75 62 73 74 66 71
Interest -5 -4 -4 -4 -7 -7 -7 -4 -9 -10
Depreciation -6 -6 -7 -10 -12 -13 -13 -17 -21 -21
Taxation -5 -6 -8 -13 -16 -10 -15 -14 -12 -12
Exceptional Items 3 -3
PAT 13 19 23 23 41 31 35 39 28 27
Minority Interest 0 0 1 3 1 -2 0 0 -1 -3
Share Associate 4
Other Related Items
Consolidated Net Profit 14 19 24 26 42 29 34 39 27 29
Adjusted EPS 16 23 28 30 49 34 40 46 31 34

Hester Biosciences Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 9 20 19 35 38 47 37 58 9 24
Cash Fr. Inv. -15 -21 -13 -30 -26 -22 -74 -38 -117 -77
Cash Fr. Finan. 7 7 -7 2 -11 3 19 -18 112 42
Net Change 2 5 -1 6 1 28 -19 1 4 -12
Cash & Cash Eqvt 4 6 5 11 12 41 24 21 25 13

Hester Biosciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73
Public 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Hester Biosciences Ltd. Announcements

View details >>
Mon, 25 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate request received from the shareholder
Wed, 20 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer report and Voting results of 36th Annual General Meeting
Wed, 20 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 36th Annual General Meeting held on 20 September 2023 which includes Proceedings Voting Results and Scrutinizer Report.

Hester Biosciences Ltd. Technical Scans

View details >>
Thu, 28 Sep 2023
High Delivery Percentage High Delivery Percentage
Closing Above Previous High Closing Above Previous High
CCI Bullish CCI Bullish
Wed, 27 Sep 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low

Hester Biosciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,640.71 1,137.55 -0.2%
Divi's Laboratories Ltd. 97,263.71 3,663.85 -2.7%
Cipla Ltd. 93,971.75 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. 90,489.91 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. 72,268.33 5,026.15 -1.5%
Mankind Pharma Ltd. 70,687.84 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. 63,140.38 1,858.55 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.36 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 65.84 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 30.20 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.16 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.09 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 55.14 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.92 1,858.55 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.71 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 7.41 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 3.86 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.69 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.77 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.57 1,858.55 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,858.55 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,858.55 +0.5%

Hester Biosciences Ltd. FAQ's

What is Hester Biosciences share price?
Can I buy Hester Biosciences shares now?
What is the Dividend Yield of Hester Biosciences?
What is the Market Cap of Hester Biosciences?
What are the key metrics to analyse Hester Biosciences?
What is the 52 Week High and Low of Hester Biosciences?
What is the trend of Hester Biosciences share price?